Latest filing published 30 Aug 2021 for Ascelia Pharma AB, €13k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Carl Bjartmar: trading record in brief
Carl Bjartmar is a declared insider of Ascelia Pharma AB, with filings sourced from Finansinspektionen. Between 20 November 2019 and 30 August 2021, the trades on record add up to 6 filings.
Every open-market trade on record is a purchase: 6 purchases worth €117k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2021 alone, the filings show 4 purchases and no sales.
A typical purchase (the median) is worth €16k.
Most recently, on 30 August 2021, the filings show an open-market purchase worth €6,471 in Ascelia Pharma AB. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. The regulation allows three business days to notify a trade (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Carl Bjartmar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,600 shares@ SEK 27.83AktieISIN SE0010573113FI:csv-3b20e9fae94c30ce8a48Canonical exit: 28 Nov 2021 (T+90)
- 2,400 shares@ SEK 27.45AktieISIN SE0010573113FI:csv-c6baec320ae019ace4f7Canonical exit: 28 Nov 2021 (T+90)
- 9,000 shares@ SEK 43.50AktieISIN SE0010573113FI:csv-b80ddedecb4f6e51be7fCanonical exit: 18 May 2021 (T+90)
- 8,000 shares@ SEK 26.139AktieISIN SE0010573113FI:csv-242e8410a9d19fc1b7daCanonical exit: 25 Nov 2020 (T+90)
- 18,000 shares@ SEK 19.38AktieISIN SE0010573113FI:csv-011a4de4fc14b5e321bfCanonical exit: 18 Feb 2020 (T+90)
5 of 5 declarations